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Abstract 
Imbalanced deoxynucleotide pools have been related to high mutagenic rates which increase 
the risk of cancer. Mitochondrial DNA (mtDNA) defects and deficiencies are observed in many 
cancer types and have also been shown to cause imbalanced deoxynucleotide pools. In mtDNA 
deficient cells the deoxynucleotide pools and ATP levels increase 30 hours after ultraviolet 
(UV)-irradiation but the reason for this increase is not fully understood. The deoxynucleotides 
are synthesized through two pathways, the de novo and salvage pathway. A key enzyme of the 
salvage pathway is the enzyme thymidine kinase 1 (TK1) which is part of the pathway 
synthesizing dTTP. The regulation of dTTP is very important as this deoxynucleotide has a 
regulatory effect on the other dNTP pools. The current study is a continuation of a recent study 
by Skovgaard [2009, paper V] which investigates whether TK1 takes part in the increase of 
dNTP pools in mtDNA-deficient UV-irradiated cells. Unfortunately we were unable to measure 
all four types of dNTP pools, only the ATP and dATP pools were measureable. Our results 
indicate that the ATP and dATP levels, in osteocarcoma cells with deficient electron transfer 
chains and lacking TK1, do not change immediately after UV-irradiation. Normal osteocarcoma 
cells were treated with oligomycin to mimic the osteocarcoma cells with deficient electron 
transfer chains. In these cells we found a statistically significant 3.1-fold increase in the ATP 
levels and a 2.5-fold increase in dATP levels 30 hours after UV-irradiation compared to the cells 
without UV-irradiation. Despite of large standard deviations in the ATP and dATP 
measurements and lack of dGTP, dCTP and dTTP results, our data seem to indicate that ATP 
and dATP pools are closely related and that the oligomycin treated cells resemble the 
osteocarcoma cells with deficient electron transfer chains and lacking TK1. This is also 
observed by Skovgaard [2009, paper V]. Therefore our results support the hypothesis of 
Skovgaard [2009, paper V], which show that TK1 plays a small or no role in the observed 
increases in dATP pools of oligomycin treated osteocarcoma cells 30 hours after UV-irradiation 
compared to the cells without UV-irradiation. Instead it is implied that the observed increase 
might be due to reduced dATP inhibition of the Ribonucleotide reductase of the de novo 
pathway.  
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Resume 
Ubalance i deoxynukleotid niveauerne er sat i forbindelse med en høj mutagenrate, hvilket 
øger risikoen for cancer. Defekter og mangler i mitokondrielt DNA (mtDNA) er observeret i 
mange cancertyper og har også vist sig at forårsage ubalance i deoxynukleotid niveauerne. I 
celler uden mtDNA stiger deoxynukleotid niveauerne og ATP-niveauerne 30 timer efter UV 
bestråling, men årsagen til denne stigning er endnu ikke fuldstændig forstået. 
Deoxynukleotider kan syntetiseres på to måder, ved de novo og salvage pathway. Et centralt 
enzym i salvage pathway er thymidin kinase 1 (TK1), som er en del af syntesen af 
deoxythymidin-trifosfat (dTTP). Reguleringen af dTTP er yderst vigtig, da dette deoxynukleotid 
har en regulerende effekt på de andre dNTP niveauer. Det aktuelle studie er en fortsættelse af 
et tidligere studie foretaget af Skovgaard [2009, papir V], der undersøger om TK1 er 
indvirkende på stigningen i dNTP niveauer i UV bestrålede celler uden mtDNA. Desværre var vi 
ikke i stand til at måle alle fire typer af dNTP niveauer, kun målinger af ATP og dATP var muligt. 
Vores resultater viser, at ATP og dATP niveauer, i osteocarcoma celler med manglende 
elektrontransportkæde og TK1, umiddelbart ikke ændres efter UV bestråling. Normale 
osteocarcoma celler blev behandlet med oligomycin for at efterligne osteocarcoma celler med 
manglende elektrontransport kæde. I disse celler fandt vi en statistisk signifikant 3,1 gang 
stigning i ATP-niveau og en 2,5 gang stigning i dATP niveau 30 timer efter UV bestråling i 
forhold til de celler, der ikke blev UV bestråling. På trods af store standardafvigelser i ATP og 
dATP målingerne og mangel på dGTP, dCTP og dTTP resultater, synes vores data at vise at ATP 
og dATP niveauerne er relaterede, og at de oligomycin behandlede celler ligner osteocarcoma 
celler uden elektrontransport kæde og TK1. Dette er også observeret af Skovgaard [2009, papir 
V]. Vores resultater støtter således Skovgaard [2009, papir V]s hypotese om at TK1 spiller en 
lille eller slet ingen rolle i den observerede stigning i dATP niveauet hos oligomycin behandlet 
osteocarcoma celler 30 timer efter UV bestråling i forhold til cellerne uden UV bestråling. I 
stedet er det foreslået, at den observerede stigning kan skyldes en mindsket dATP hæmning af 
ribonukleotid reduktase i de novo pathway.  
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1 Introduction 
Mutations in the genome can have both positive and negative consequences. On one hand 
mutations are the basis of evolution, continuously giving rise to new abilities and species. On 
the other hand mutations are the underlying reason for a wide variety of diseases and 
dysfunctions. Mutations are spontaneous and can arise in any part of the genome during 
replication, which is why the cell tightly regulates all processes that could increase the 
mutational rate. In 1925 a link between the mitochondria and cancer was suggested [Jackson 
et al. 1930], and since then mitochondrial deoxyribonucleic acid (mtDNA) mutations have been 
associated with cancer in many tissues [Birch-Machin & Swalwell 2009; Singh et al. 2005]. The 
connection between mtDNA mutations and cancer has been linked to mtDNAs central role in 
oxidative stress production [Rasmussen et al. 2003] and its role as a mediator of apoptosis 
[Birch-Machin & Swalwell 2009; Singh et al. 2005]. Earlier experiments have demonstrated that 
defects in the mitochondrial respiratory chain lead to decreased deoxyribonucleic acid (DNA) 
repair, thereby increased damage and mutation rates in the nuclear DNA (nDNA) [Singh 2004; 
Singh et al. 2005; Rasmussen et al. 2003; Delsite et al. 2003], and increased resistance to 
apoptosis [Park et al. 2004; Singh 2004]. Furthermore several studies have found that 
imbalances in the deoxynucleotide triphosphate (dNTP) pools increases the rate of mutations 
[Bebenek & Kunkel 1990; Bebenek et al. 1992; Ke et al. 2005]. These changes in the cellular 
phenotype are all known to increase the risk of cancer [Singh & Kulawiec 2009]. Since defects 
in the mtDNA and imbalances in the dNTP pools both have been associated with cancer a 
possible connection between defects in the mtDNA and imbalances in the dNTP pools are 
investigated.  
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1.1 The mitochondria 
The mitochondria is an oval organelle, about 1–10 µm long, that is constantly changing its 
shape. The mitochondria are implicated in several functions in the cell such as control of 
apoptosis, growth, development, and various metabolic pathways [Singh & Kulawiec 2009]. 
However its primary purpose is oxidative phosphorylation [Modica-Napolitano & Singh 2004].  
Many copies of the protein complex ATP synthase (ATPase) are located on the mitochondrial 
inner membrane. The ATPase produces adenosine triphosphate (ATP) from adenosine 
diphosphate (ADP) and inorganic phosphates and is powered by the flow of hydrogen ions 
across the mitochondrial inner membrane. Therefore, maintaining the proton gradient is 
crucial for the ATPase. The proton gradient is maintained by the electron transport chain (ETC) 
which is also located in the inner mitochondrial membrane. The ETC consist of five complexes 
which pump H+ out of the mitochondrial matrix to create the proton gradient. Together, the 
ETC and the ATPase compose oxidative phosphorylation and is the main ATP source in 
eukaryotic cells. 
A known inhibitor of the ATPase is oligomycin, which inhibits the ATPase by blocking its proton 
channel [Nakata et al. 1995]. After inhibition by oligomycin the ETC continues to transfer H+ 
out of the matrix until the proton gradient outside gets too large and causes the ETC to arrest 
[Nakata et al. 1995].  
The mitochondria are found in almost all eukaryotic cells, some cells have a single 
mitochondrion but most frequently a cell have hundreds or even thousands of mitochondria. 
The human mitochondria have their own DNA, the mtDNA, and their genome is a closed 
circular double helical molecule. The mtDNA molecules are much smaller than the nuclear 
chromosomes, only 16,569 bp in humans encoding 37 genes. The mtDNA is mainly concerned 
with the production of energy; it encodes 13 proteins of the ETC. The residual components 
encoded by the mtDNA are 22 transfer ribonucleic acids (tRNA) and two ribosomal ribonucleic 
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acids (rRNA) required for the translation of the mtDNA. However the mitochondrion is not 
autonomous because it also relies on nuclear genes.  
Each mitochondrion normally has between two and ten copies of their mtDNA and up to 
thousands of mitochondria can be present in a cell simultaneously. Thus mtDNA can form a 
mixture of both wild-type and mutant mtDNA within a cell [Birch-Machin & Swalwell 2009]. 
The presence of mutated mtDNA is functionally recessive and cellular dysfunction only occurs 
when the ratio of mutated mtDNA are three times higher than the wild-type mtDNA [Birch-
Machin & Swalwell 2009]. However, the mtDNA is very compact and does not contain introns 
and mutations in the mtDNA are therefore very likely to affect a coding region [Shadel & 
Clayton 1997; Singh et al. 2005]. The mtDNA also lacks some of the efficient DNA repair 
mechanisms that are present in the nucleus and is for example unable to repair ultraviolet 
(UV)-induced photoproducts such as pyrimidine dimers [Birch-Machin & Swalwell 2009]. The 
mtDNA does not have any protective histones and is therefore exposed to harmful reactive 
oxygen species generated by oxidative phosphorylation and the replication of mtDNA might be 
error prone [Singh et al. 2005]. These facts fits well with the general observations that the 
mutation rate in mtDNA generally is ten times larger than that in nuclear DNA [Singh et al. 
2005]. 
 
1.2 Experimental cell lines 
The cells used in this experiment are all human osteosarcoma cells originated from the same 
host. HOS (TK+ ρ+) is the original cell line but also two derivatives of the HOS cell line are used. 
The 143B (TK- ρ+) cell is one of the cell lines derived from HOS and lacks the enzyme thymidine 
kinase 1 (TK1) [Skovgaard 2009, paper V], which is one of the key enzymes in the biosynthesis 
of nucleotides [Ke et al. 2007]. 143B ρ0 (TK- ρ0) is the second cell line derived from HOS cells. 
These cells are TK- as the 143B cells and furthermore the mtDNA has been removed (ρ0). The 
removal of mtDNA can, as an example, be done with ethidium bromide, which damages DNA 
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and inhibit mitochondrial DNA replication [King & Attardi 1989] or by a targeted mitochondrial 
expression of a restriction endonuclease to deplete mitochondrial DNA [Nass et al. 2009]. As 
mentioned the mtDNA encodes multiple subunits in the ETC, and thus when removed the ETC 
is functionally inoperative. 
In cells that contain functional mtDNA, uridine monophosphate (UMP) and cytidine 
monophosphate (CMP), which subsequently is phosphorylated to uridine diphosphate (UDP) 
and cytidine diphosphate (CDP), is synthesized from small precursors in a series of reactions 
beginning with the synthesis of carbamoyl phosphate by the enzyme Carbamoyl-phosphate 
Synthetase (CPSase). The CPSase controls the flow through the pyrimidine de novo pathway 
and is, among other things, regulated by UTP feedback inhibition [Evans & Guy 2004; Jones 
1980]. The enzyme dihydroorothate dehydrogenase (DHODHase), which is integrated in the 
inner mitochondrial membrane, is also a part of this pathway. DHODHase catalyzes the 
reaction of dihydroorothate to orothate and the final electron acceptor in this reaction is 
ubiquinone which is also involved in the ETC. When removing the mtDNA the DHODHase is no 
longer active in the cell, hence TK- ρ0 cell lines are forced to rely solely on the salvage pathway 
for pyrimidine nucleotides. 
Furthermore the cells are unable to make ATP by oxidative phosphorylation and the TK- ρ0 cells 
rely on glycolysis to fulfill their energy demands [King & Attardi 1989]. The nicotinamide 
adenine dinucleotide with an attached hydrogen (NADH) produced in the glycolysis would 
under normal conditions be converted to nicotinamide adenine dinucleotide (NAD+) by 
donating an electron pair to the enzyme NADH dehydrogenase, complex I, in the ETC. When 
the oxidative phosphorylation does not function the NADH will not have a receiver and the 
NAD+ will be depleted. This depletion can be accompanied by a stop in the glycolysis. To avoid 
this it is necessary to supplement the cells nutrients with pyruvate and uridine [Grégoire et al. 
1984]. Pyruvate is converted into lactate by the enzyme lactate dehydrogenase and this 
reaction produces NAD+. In this manner the glycolysis can continue the production of ATP in 
the TK- ρ0 cells [López-Lázaro 2008]. Uridine is added to make sure the pyrimidine synthesis 
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can continue when the ETC, and thereby also the DHODHase, does not function [King & Attardi 
1989]. Uridine is also converted into UDP and function as a coenzyme-like carrier in the 
conversion of galactose to glucose which is used to produce ATP in the glycolysis. 
 
1.3 The cell cycle and dNTP pools 
In normal human cells one cell division might be seen approximately every 24 hours but it can 
vary between tissues. The cell cycle including the division is divided into four phases; G1 phase 
called “first gap”, G2 phase called “second gap”, S phase called “synthesis” and M phase called 
“Mitotic phase” (figure 1.3-1). The growth is initiated in G1 phase and the length of the G1 
phase varies the most between cell lines. The whole chromosome is replicated in the S phase, 
along with synthesis of histones, RNA and proteins. The cell continues to grow in this phase 
while replicating the DNA and thus the S phase is often the longest and takes 10-12 hours. The 
S phase is followed by G2 where the cell still grows and completes the preparations for cell 
division. G2 is usually short and ends in the M phase where the cell divides. Furthermore the G1 
and G2 phases constitute a decision making period where molecular signaling decides whether 
to divide or continue growing. In fact there is a major regulatory point (R) in G1 phase which 
inhibits all progression to S phase if the cell is not ready to divide. This ensures that the cell 
does not use large energy resources in replication without proceeding to mitosis (figure 1.3-1). 
 
 
 
 
 
 
Figure 1.3-1 The cell cycle with the four phases and the 
major regulatory point (R) in the G1 phase [Edited from 
Vidensbanken.blogspot.com]. 
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The cell cycle can be affected by mutagenic agents such as UV-irradiation which can cause cells 
to arrest in a phase or to bypass regulatory mechanisms and proceed to the next phase with 
severe DNA damage [Siede et al. 1994]. UV-irradiation has been shown to cause delays in the 
completion of S phase and an extended arrest in the G1 phase in Chinese hamster ovary cells 
[Orren et al. 1997]. Skovgaard [2009, paper V] also observed an arrest in osteosarcoma cells 
and furthermore an accumulation of cells in S phase for 18 hours before they were released to 
G2 phase. The arrest in S or G2 phase is connected to the DNA damage induced by the UV-
irradiation. The cell delays the entry to a new phase until the DNA damage is repaired. This is 
called a checkpoint and these exist in G1, S and G2 phase. Checkpoints ensure that all DNA is 
synthesized properly and that the cell is ready for mitosis [Kastan & Bartek 2004; Hartwell & 
Weiner 1989]. 
In normal cells the dNTP pools vary greatly during the cell cycle and because of this it is 
important to know which phase the cells are in when the dNTP pools are measured. In S-phase 
the dNTP pools increase precipitously. Then, when entering the G2/M-phase they decrease 
until they reach low levels seen in G1-phase. The differences within the dNTP pools vary 
between the cell lines and there are even variations within the same cell line. But for the most 
part it seems like the purine pools are usually smaller than the pyrimidines and the 
deoxycytidine triphosphate pools is often largest while the deoxyguanosine triphosphate pool 
is smallest [Reichard 1988; Skoog et al. 1973;]. When the dNTP pool distribution changes 
following cell cycle they are a part of their own regulatory mechanism. This is one of the cells 
options to ensure that there is the right amount of each of the dNTP pools when the DNA 
synthesis initiates. 
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1.4 The biosynthesis of dNTPs 
To replicate and repair DNA, mammalian cells need four types of dNTPs, deoxyadenosine 
triphosphate (dATP), deoxyguanosine triphosphate (dGTP), deoxycytidine triphosphate (dCTP) 
and thymidine triphosphate (dTTP). Balanced dNTP pools are essential for the fidelity of DNA 
synthesis and thereby a low mutation frequency [Ke et al. 2005]. dNTPs are synthesized via the 
de novo or salvage pathways (figure 1.4.2-1). The cells adjust to a constant change in the 
demand for dNTPs by having two different pathways that can produce dNTPs and by having 
several regulation systems for the key enzymes in both pathways [Reichard 1988]. 
 
1.4.1 The de novo pathway 
The de novo pathway synthesizes dNTPs from small precursors. This process is highly energy 
demanding and requires several relevant enzymes to produce one dNTP [Reichard 1988]. One 
of the key enzymes in this pathway is the ribonucleotide reductase (RNR) which catalyzes a 
reduction. This reduction also acts as the first rate-limiting step in this pathway [Håkansson et 
al. 2006]. Adenosine diphosphate (ADP), guanosine diphosphate (GDP), cytidine diphosphate 
(CDP) and uridine diphosphate (UDP) are all substrates of RNR. The RNR catalyzes the 
substitution of the 2´-OH-group on the ribonucleotide diphosphate with an H atom [Nordlund 
& Reichard 2006] and after the reduction, deoxyadenosine diphosphate (dADP), deoxycytidine 
diphosphate (dCDP) and deoxyguanosine diphosphate (dGDP) are phosphorylated to form 
dATP, dCTP and dGTP by the enzyme nucleoside diphosphate kinase (NDK). The formation of 
dTTP is more complicated than the formation of the other dNTPs, and dTNPs are produced in 
several steps from deoxyuridine diphosphates (dUDP) and dCDPs (figure 1.4.2-1) [Reichard 
1988]. 
RNR has two homodimeric proteins, R1 and R2 which contains a reductase and a radical 
generator respectively [Eklund et al. 2001]. The R1 subunit carries an active site which is the 
reductase, a specificity site where regulation decides which specific dNTPs are reduced and an 
activity sites where the RNRs overall activity is regulated [Nordlund & Reichard 2006]. The R2 
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subunit contains the radical generator which is an iron center that generates one tyrosyl 
radical. The tyrosyl radical is used in the first step of the reaction where the substrate is 
oxidized to a radical form. The reduction is then completed by two cysteine residues in the 
active site. These R1 and R2 subunits combine with two R1 and two R2 to create the RNR 
enzyme with two active sites and two iron-tyrosyl centers [Eklund et al. 2001] (figure 1.4.1-1). 
 
Figure 1.4.1-1 The RNR enzyme with the two subunits R1 and R2. S: Specificity site, Ac: Activity site, A: Active site [Edited 
from Eklund et al. 2001]. 
 
RNR is controlled by several regulatory systems that maintain balanced dNTP pools during 
deoxyribonucleic acid (DNA) replication and repair [Reichard 1988]. The active form of RNR is 
restricted to the S phase and the de novo pathway is the main pathway for synthesizing dNTPs 
in this phase [Engström et al. 1985]. RNR is regulated by S-phase specific transcription of the 
R1 and R2 genes [Björklund et al. 1990], binding of nucleoside triphosphate as allosteric 
effectors to the R1 subunit [Reichard et al. 2000], and degradation of the R2 subunit [Chabes et 
al. 2003, B]. The R1 protein has a half-life of more than 20 hours whereas the R2 protein only 
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has a half-life of 3 hours [Chabes & Thelander 2000; Eriksson et al. 1984] which gives a 
constant level of R1 all trough cell cycle. Instead it is the short-lived R2 subunit which controls 
the presence of RNR [Chabes et al. 2003, B]. In late G1-phase and during S-phase, the 
transcription of RNR is regulated by transcription factor E2F-1 [Degregori et al. 1995]. E2F-1 
forms a dimer with DP-1 and 2 increasing the affinity of E2F-1 for DNA where after it binds to 
specific sequences in the RNR genes, enhancing the transcription [Degregori et al. 1995; Wu et 
al. 1995].  The overall activity of RNR is regulated in the activity site by ATP and dATP. While 
ATP functions as an activating effector, dATP functions as a general inhibitor [Anderson et al. 
2000]. In the allosteric regulation of RNR, ATP, dGTP, dTTP and dATP are effectors that bind to 
the specificity site of RNR and function as both positive and negative effectors. dGTP and dTTP 
activates reduction of dATP and dGTP respectively and while dGTP inhibits both dTTP and 
dCTP, dTTP only inhibits dCTP. ATP and dATP are both positive effectors for CDP and UDP 
[Eklund et al. 2001]. dATP has in this sense both a general negative effect in the activity site 
and a positive effect in the specificity site for UDP and CDP. The affinity for dATP in the 
specificity sites is much higher than in the activity site and the concentrations of dATP need to 
be very high before the inhibitory effect is significant [Kolberg et al. 2004]. The activity of RNR 
from calf thymus has been found to be 50 % inhibited with concentrations of 1-5 µM dATP and 
1 mM ATP [Eriksson et al. 1979]. Furthermore, all the end-products, the dNTPs, are feedback 
inhibitors shutting down their own production in the specificity site if their concentration 
increases too much (figure 1.4.1-2) [Eklund et al. 2001].  
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Figure 1.4.1-2 RNR regulation. The red bars are the feedback inhibition from the dNTPs. The green arrows symbolize 
activation and the red arrows symbolize inhibition [Edited from Skovgaard PhD 2009; Eklund et al. 2001]. 
 
When the cells terminate the replication the R2 subunit is degraded in the mitosis by 
proteolysis. The N-terminal in the R2 subunit has a KEN box which is a substrate for a 
proteolysis complex called Cdh1-anaphase-promoting complex (Cdh1-APC) [Chabes et al. 2003, 
B]. In the S-phase phosphorylation of the Cdh1 causes it to disassociate from anaphase 
promoting complex (APC) which is then inactive and the R2 is stable. When the cell enters 
mitosis, cell cycle dependent dephosporylation of the Cdh1 activates the Cdh1-APC complex 
and by that the R2 degradation [Chabes et al. 2003, B]. 
Outside S-phase dNTPs for DNA repair and replication of mitochondrial DNA are supplied 
mostly by the salvage enzymes and by low levels of another recently found version of RNR, 
p53R2. RNR consists of the R1 subunit and the p53R2 subunit [Guittet et al. 2001]. p53R2 is a 
transcriptional target of p53 which is tumor suppressor gene and functions as a transcription 
factor. p53 normally participates in DNA repair, cell cycle arrest and apoptosis. When the cell is 
damaged p53 is activated and determines the cells fate and either repair the damages while 
preventing cell cycle progression or induce apoptosis [Latonen & Laiho 2005; Nakano et al. 
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2000]. It has been shown that an upregulation of p53 induces the expression of p53R2 in 
response to DNA damage [Nakano et al. 2000] while the R2 subunit promoter is not affected 
[Guittet et al. 2001]. Furthermore as a response to UV-irradiation the transcription factor E2F-1 
is up-regulated due to prolonged half life [Blattner et al. 1999] which it is thought to 
upregulate the expression of R1. In this way the R1-p53R2 complex supplements the cell with 
dNTPs both outside S-phase [Håkansson et al. 2006] and for DNA repair when the cell is 
affected by DNA damaging agents [Tanaka et al. 2000]. 
 
1.4.2 The salvage pathway 
The de novo pathway is complemented by the salvage pathway, which is shorter and less 
energy demanding because of direct phosphorylation of deoxynucleosides (dNs). The dNs are 
imported from extracellular compartments or derived from intracellular dephosphorylation of 
deoxynocleotides [Al-Madhoun et al. 2004]. Some of the key enzymes used to synthesize dNTP 
in the salvage pathway are deoxynucleoside kinases (dNKs). dNKs catalyze the first and rate 
limiting step in the synthesis of dNTPs which is the synthesis of deoxynucleotide 
monophosphates (dNMPs) from dNs [Arnér & Eriksson 1995]. The initial phosphorylation 
reaction also leads to trapping of the now charged nucleotides inside the cell (figure 1.4.2-1) 
[Al-Madhoun et al. 2004].  
There are four different dNKs in mammalia; thymidine kinase 1 (TK1), deoxycytidine kinase 
(dCK), deoxyguanosine kinase (dGK) and thymidine kinase 2 (TK2). TK1 and dCK are located in 
the cytosol, and TK2 and dGK are located in mitochondria [Jüllig & Eriksson 2000]. TK1 
phosphorylates thymidine (dThd), but it also accepts deoxyuridine (dUrd) [Arnér & Eriksson 
1995; Reichard 1988]. dCK phosphorylates deoxycytidine (dCyd), deoxyguanosine (dGuo) and 
deoxyadenosine (dAdo). Hence the two cytosolic enzymes, TK1 and dCK, are capable of 
phosphorylating all four deoxynucleosides (figure 1.4.2-1). TK2 phosphorylates dThd and dCyd 
whereas dGK phosphorylates dGuo and dAdo and thus these two mitochondrial enzymes are 
also capable of phosphorylating all four deoxynucleosides [Arnér & Eriksson 1995]. 
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The human TK1 enzyme (HuTK1) catalyzes the transfer of a phosphate group from a phosphate 
donor, for example ATP, to the phosphate acceptor dThd or dUrd [Al-Madhoun et al. 2004]. 
The TK1 is a complex of two or four identical subunits, where each subunit contains a dTTP 
binding site, an ATP binding site, two protein-protein interaction sites and a KEN-box involved 
in TK1 degradation [Ke and Chang 2004; Welin et al. 2004].  
Two different protein-protein interfaces, interface I and II, connect the TK1 subunits. Interface 
I is the strongest connection and is presumably used in active dimer formation while interface 
II is the weakest connection and is used when forming tetramers from two dimers [Welin et al. 
2004; Segura-Pena et al. 2007 A; Kosinska et al. 2007]. The enzyme has a catalytic function in 
both its dimer and tetramer formation but the tetramer has a higher catalytic efficiency than 
the dimer [Munch-Petersen et al. 1993]. The tetramer is however not active without bound 
ATP as the binding of ATP stabilizes an open and active formation of the tetramer [Segura-Pena 
et al. 2007 B]. The formation of the active tetramer is highly dependent on both enzyme and 
ATP concentrations and the formation of active tetramers is suggested to be a regulatory 
mechanism [Munch-Petersen et al 2009]. 
The TK1 of Thermotoga maritima (TmTK1) has been investigated and it has been found that 
that when it is bound in tetramers it can exists in two states, a closed inactive state and an 
open active state. Without ATP present the enzymes is in its closed inactive state but when 
ATP is present the ATP binds to the enzyme altering the weak interface, thus creating an open 
and active enzyme. Based on these findings it has been suggested that the TmTK1 continuously 
oscillates between the open and closed tetrameric state with ATP stabilizing the open active 
state [Segura-Pena et al. 2007]. This model has also been proposed for HuTK1 thereby 
explaining the positive cooperativity of the HuTK1 with ATP [Skovgaard 2009; Munch-Petersen 
1984] 
TK1 is the one of the four kinases with the strictest regulation. The regulation of TK1 is 
dependent on cell cycle and feedback inhibition by dTTP [Reichard 1988]. The expressed level 
of TK1 is significantly increased in the transition state between G1 and S phase through its 
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transcriptional and translational controls [Coppock & Pardee 1987; Stuart et al. 1985]. 
Transcription of the TK1 gene is induced by several factors including E2F, which is also a 
transcription factor for RNR [Hu & Chang 2007].  During the transition from G2 to M phase, 
human TK1 accumulates and becomes phosphorylated [Chang et al. 1994; Chang et al. 1998]. 
In mitosis TK1 is degraded by Cdh1-APC recognition of a KEN box located in the C-terminal [Ke 
& Chang 2004; Kauffman & Kelly 1991] which results in low levels of the enzyme in the G1 
phase [Kauffman & Kelly 1991]. Thereby, the expression of TK1 changes during the cell cycle 
and increases in the S-phase [Kauffman & Kelly 1991; Sherley & Kelly 1988]. 
Wei et al. 1999 determined that enzymes involved in the purine pathway were hardly affected 
by radiation, but the activities of TK1 were increased after γ-irradiation treatment. The 
increased activity of TK1 correlated with similar increases in protein level and was not due to 
cells entering S-phase [Wei et al. 1999]. These results indicate that TK1 increases as a response 
to DNA damage. 
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Figure 1.4.2-1 The de novo and salvage pathway. 
1.5 The connection between mitochondrial DNA, dNTP pools and cancer 
If mutations occur in the genome and accidentally activate oncogenes or inactivate tumor 
suppressor genes, cancer can arise. It is therefore likely that cells with high mutational rates 
have a higher risk of developing into cancer cells, which is supported by the fact that most 
tumors are genetically unstable [Lengauer et al. 1998]. 
Mitochondrial dysfunction and mtDNA mutations have, been reported in numerous types of 
cancer [Modica-Napolitano et al. 2004; Hochhauser 2000]. High glycolytic activity has been 
observed in cancer cells, even in the presence of sufficient oxygen. Thus it has been proposed 
that dysfunctional mitochondrial oxidative phosphorylation could be a cause of carcinogenesis 
[Modica-Napolitano et al. 2004]. Indeed, lack of mtDNA or inhibition of the ETC has proven to 
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be mutagenic in yeast cells, partly acting through the translesion synthesis (TLS), which is a 
mechanism designed to bypass DNA damage using error prone DNA synthesis [Rasmussen et 
al. 2003].  
One possible connection between dysfunctional oxidative phosphorylation and carcinogenesis 
could be increased levels of reactive oxygen species (ROS), as inhibition of the oxidative 
phosphorylation increases the levels of ROS, and increased levels of ROS are observed in 
numerous cancer types [Esposito et al. 1999]. Cells missing part of or all their mtDNA have, in 
contrast to cells with inhibited ETC, shown a decrease in ROS but also a heightened sensitivity 
to ROS [Rasmussen et al. 2003; Delsite et al. 2003].  
Another possible way the lack of mtDNA could result in mutations in the nuclear DNA is 
through imbalanced dNTP pools. Balanced dNTP pools are crucial for the fidelity of DNA 
synthesis and imbalanced dNTP pools are known to cause frameshift mutations, base pair 
substitutions and gross chromosomal rearrangements by delaying the DNA replication fork 
progression [Ke et al. 2005; Darè et al. 1995; Bebenek & Kunkel 1990]. Frameshift mutations as 
a result of imbalanced dNTP pools are explained by slippage of the synthesized strand after 
misincorperation of a dNTP in excess. This model predicts an observed high frequency of one 
base pair deletion, where the deleted base pair has a 5´end neighbor complementary to the 
dNTP in excess on the template strand [Bebenek & Kunkel 1990]. Base pair substitutions are 
formed by incorporation of the dNTP in excess, and gross chromosomal rearrangements are a 
result of slowed replication fork progression during replication and strand breaks. Cells with 
defective DNA repair mechanisms have proved to be more sensitive to imbalanced dNTP pools 
supporting the theory that imbalanced dNTP pools directly affects the DNA replication [Darè et 
al. 1995; Mohindra et al. 2002; Bolderson et al. 2004]. 
Lack of mtDNA in cells has shown to alter the size of dNTP pools in different cells, mainly 
decreasing the pool sizes [Desler et al. 2007]. Synthesis of dNTPs are highly dependent on ATP, 
and with mitochondria as the major ATP supplier, it is possible that ATP levels are too low to 
maintain synthesis of dNTPs. The activity of one of the key enzymes in the salvage pathway, 
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the TK1, has been investigated and showed no decrease in mtDNA deficient HeLa cells but did 
show a decrease in human skin cancer cells [Desler et al. 2007]. 
One important factor, considering how cells keep a high fidelity in replicating the genome, is 
how the cells react to DNA damage. Studies have showed that yeast cells show an increase in 
dNTP pools after induced DNA damage with UV-irradiation and two other DNA damaging 
agents. The increase in dNTP pools results in higher survival rates as well as higher mutational 
rates, and is possibly a consequence of a more relaxed RNR inhibition by dATP [Chabes et al. 
2003, A]. In contrast mammalian cells containing functional mtDNA do not show an increase in 
dNTP pool sizes after induced DNA damage which indicates differences in the regulation of 
dNTP synthesis between mammalian cells and yeast [Håkansson et al. 2006]. However, in 
human osteosarcoma TK- ρ0 cells, which are deficient for TK1 and mtDNA, an increase in dNTP 
pools after UV-irradiation has been established [Skovgaard 2009, paper V].  
 
1.6 Experimental purpose  
The purpose of this experiment is to investigate the link between lack of mtDNA and changes 
in dNTP pools after UV induced DNA damage, and thereby to gain further insight into the role 
of dysfunctional mtDNA and TK1 in carcinogenesis. As it has previously been shown, dNTP 
pools of human osteosarcoma cells without mtDNA increase after UV-irradiation, and lack of 
mtDNA affects the activity of HuTK1 in some cell lines [Skovgaard 2009, paper V; Desler et al. 
2007]. Therefore we have decided to investigate a possible role of TK1 in the mentioned 
observations, regarding the increase in dNTP pools after UV-irradiation in ρ0 cell lines. This is 
done through experiments with TK+ ρ- cells, and by comparing our results with those obtained 
by Skovgaard 2009 [paper V]. 
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2 Materials and methods 
2.1 Cell lines 
The three cell lines HOS (ATCC no.: CRL-1543), 143B (ATCC no.: CRL-8303) and 143B ρ0 
(available in our laboratory) are Human osteosarcoma cells originating from the same host. 
HOS are normal (TK+ ρ+), 143B are deficient for TK1 (TK- ρ+) and 143Bρ0 are TK- and without 
mitochondrial DNA (TK- ρ0). The TK- ρ0 cells were obtained by Singh [et al. 2005] and initially 
derived from 143B cells by use of ethidium bromide [Singh et al. 2005; Manfredi et al. 1999]. 
HOS cells treated with oligomycin are referred to as TK+ ρ-. The cell lines where grown in 
Dulbecco’s Modified Eagle’s Medium (DMEM) containing glutamax (Gibco/Lonza) with the 
supplementation of 1% streptomycin/penicillin for all cell lines. Besides, TK+ ρ+ cells were 
supplemented with 7.5% fetal calf serum (FCS) (Biochrom AG Lot nr. 0739) TK-ρ+ with 10% FBS 
and TK- ρ0 with 10% FBS, and 200µM uridine.  
 
2.2 Experiments 
Two experiments with the cell lines were carried out. The first with the intention of measuring 
ATP and dNTP levels in all three cell lines just prior to, and immediately after UV-irradiation. 
And the second with the intention of measuring ATP and dNTP in HOS and HOS ρ- before UV-
irradiation, immediately after UV-irradiation and for every sixth hour after UV-irradiation for 
up to 30 hours. In both experiments the number of cells and the cell sizes were recorded by 
Beckmanns Coulter Counter Z2. 
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2.2.1 Experimental procedures 
In both experiments, between 5x105 and 1.3x106 cells were seeded on 175 cm2 Petri dishes in 
25 ml media, 48 to 78 hours prior to UV-irradiation. In the experiment with HOS ρ- 25 µl of 25 
mg/ml oligomycin in 96% EtOH was added to the Petri dishes 24 hours prior to UV-irradiation 
of the first plate. Immediately before UV-irradiation all Petri dishes were washed twice with 10 
ml 37˚C DPBS. The cells were UV-irradiation for 20 seconds for HOS and 40 seconds for 143B 
and 143B ρ0 cells with the intensity of 20 mW at 254 nm, equivalent of the cell lines LD50 
[Skovgaard 2009, paper V]. After UV-irradiation the cells were either harvested or supplied 
with 25 ml fresh preheated media.  
When harvesting, the cells were first washed twice in DPBS (Lonza), except for the cells 
harvested immediately after UV-irradiation as they had already been washed, then trypsinated 
for 5 min. at 37˚C with 1.5 ml of 0.05% trypsin 0.02% EDTA in DPBS, and finally resuspended in 
5 ml of ice cold DPBS. 
 
2.2.2 ATP measurements 
For ATP measurements we used the ATP Lite kit (Perker Elmer). Half a million cells were 
washed twice with DPBS and resuspended in 330 µl of DPBS, resulting in a cell concentration of 
1.5x106 cells/ml. As described in the kit pamphlet, 100 µl of cell solution was distributed to 
each well, a 50 µl lysis solution was added and finally 50 µl of the buffer solution containing 
lucifarese was added. The luminescence was subsequently measured in a Wallac Trilux 1450 
Microbeta liquid scintillation counter. Standard curves were made on the same plate, each well 
containing water, 100 pmol ATP, 500 pmol ATP and 1000 pmol ATP. 
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2.2.3 dNTP measurements 
The cell preparations and the following dNTP measurements were made using the DNA 
polymerase based assay technique described in “Desler C. et al. 2007” with some 
modifications. 
2x106 cells where washed twice in DPBS and resuspended in 1 ml 60% methanol resulting in a 
concentration of 2x106 cells/ml. The mixture was then incubated at -20˚C for 90 min, heated to 
100˚C for 3 min. in a heating block and centrifuged for 15 min. at 13000g where after the 
supernatant was frozen for later use by dipping the vials in liquid nitrogen. 
For the dNTP measurements the frozen cell extracts were evaporated in a vacuum centrifuge 
for up to 6 hours and the pellet was resuspended in 300 µl Ultra pure H2O from (Gibco). [
3H]-
dATP (dATP*) and [3H]-dTTP (dTTP*) solutions of 1 mCi/ml were also evaporated the same 
way, though for a much shorter time period, and resuspended in Ultra pure H2O to a 
concentration of 0.2 mCi/ml. Primers and templates were annealed by adding 20 µl of 4 mM of 
each dNTP template and 20 µl of 4 mM universal primer to 760 µl of Ultra pure water, heating 
it to 70˚C in a heating block and cooling it over 3-4 hours turning the heating block of. The 
template sequences used were: 
dTTP: 5’ –TTA TTA TTA TTA TTA TTA GGC GGT GGA GGC GG-3’ 
dCTP: 5’ –TTT GTT TGT TTG TTT GTT TGG GCG GTG GAG GCG-3’ 
dGTP: 5’ –TTT CTT TCT TTC TTT CTT TCG GCG GTG GAG GCG-3’  
dATP: 5’ –AAA TAA ATA AAT AAA TAA ATG GCG GTG GAG GCG-3’ 
Reaction mixtures were made in the proportions 5 µl 0.2 Ci/ml (H20) dATP* or 0.2 Ci/ml (H20) 
dTTP*, 5 µl of one of the four dNTP template/universal primer mixes, 0.1 µl of 10 U/µl klenow 
fragment (Fermentas), 10 µl of 500 mM Tris-HCl, 50 mM MgCl2, 10 mM DTT klenow buffer and 
64.1 µl of Ultra pure water. The reaction was started by adding 85 µl of the reaction mix to 15 
µl cell extract or 15 µl standard solution dNTP concentrations of 0 µM, 0.13 µM, 0.27 µM, 0.40 
µM and 0.67µM. Each reaction was left running for exactly 30 min. in a 37˚C water bath where 
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after 4*10 µl were spotted on DE-81 paper discs (Whatman).  The papers were washed three 
times for 10 min. in a 0.5 M HCl-, 0.2 M KCl-solution, one time for 10 min. in demineralized 
water, eluted with 0.5 ml 5% Na2HPO4 and radioactivity was counted in a Wallac Trilux 1450 
Microbeta liquid scintillation counter, using 2.5 ml Ultimate Gold (Perker Elmer) as scintillation 
fluid. 
 
2.3 Testing dATP* 
To test if the dATP* had degraded to dADP* or deoxyadenosine monophosphate* (dAMP)* we 
used Thin layer Chromatography (TLC) with 0.8 M LiCl2 as the mobile phase. 2.5 µl of single 
dAMP and ADP, 8 µl of a dAMP, dADP and dATP mixture and 10 µl of the mixture with 
dATP*was spotted on a Polygram cel 300 PEI/UV 254 sheet (Macherey-Nagel). The TLC was run 
for approximately 2 hours and stopped before the mobile phase touched the top of the sheet. 
The spots were visible in ultra violet light and were cut out and eluted in 0.1 M HCl, 0,2 M KCl. 
The dATP* was counted in a Wallac Trilux 1450 Microbeta liquid scintillation counter, using 2.5 
ml Ultimate Gold (Perker Elmer) as scintillation fluid. 
 
2.4 Statistics  
To investigate if there is a significant deviation of ATP and dNTP pool sizes between the 
different cell lines, and between the same cell lines at different intervals after UV-irradiation, 
we used the students T-test. A p-value of less than 5 % is considered statistically significant.  
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3 Results  
The relation between lack of mtDNA and imbalanced dNTPs pools have been investigated 
through several setups. The purpose of these setups was to investigate the influence of TK1 on 
the increasing dNTP pools observed in osteosarcoma cells lacking mtDNA. 
The dNTP pools were measured, as described in the method, with radioactive labeling. dTTP* 
was used to measure the dATP pools and dATP* was used to measure dTTP, dGTP and dCTP 
pools. Unfortunately only the dATP measurements were successful. Since the errors occurred 
when measuring dTTP, dCTP and dGTP, and these were subjected to the same experimental 
procedure regarding their radioactive agent, dATP*, it is evident that a degradation of the 
dATP* could have caused the lack of results. Hence this was examined and is presented in 3.2 
Investigation of dATP*.  
 
3.1 Growth rate 
 The three cell lines were each plated in 4 wells and one well per cell line were counted each 
day over a period of 4 days (figure 3.1-1). This was done to investigate if the cells grew as 
expected and thereby get an idea of the cells condition and to plan the setup of the following 
experiments. The growth rates were calculated and showed exponential increases.   
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Figure 3.1-1 Growth curve of the TK+ ρ+, TK- ρ+ and TK- ρ0 cell lines. 
104 TK+ ρ+ cells, 104 TK- ρ+ cells and 2x104 TK- ρ0 cells were plated, but only 15-40 % was still 
living after 25 hours. The last samples of the TK- ρ+ and TK- ρ0 in the growth curves are lower 
than expected if the curves were plottet for only the three first measurements. This results in a 
slower growth than the first three samples would have predicted and thus may not be entirely 
correct. The deviations of the last measurements were highest for the TK- ρ0. The calculated 
doubling times for the TK+ ρ+ and TK- ρ+ cells are 12 and the TK- ρ0 cells 14 hours.  
 
3.2 Investigation of dATP*  
The lack of results from the dNTP measurement is represented by the four standard curves 
(Figure 3.2-1). It is evident that the standard curves for dTTP, dGTP and dCTP are almost 
straight horizontal lines while the dATP curve is increasing. The small amounts of 60-100 CPM 
seen in the standard curves are as low as the water sample and can therefore be discarded as 
background noises. Thus it is likely that the dATP* was not incorporate into the DNA strand. 
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Figure 3.2-1 Standard curves for dTTP, dGTP, dCTP and dATP. Standards of water, 2, 4 and 6 pmol of dNTPs 
where measured with the scintillation counter. The error bars are S.D. of four measurements. 
To investigate if the dATP* were degraded, we examined the concentrations of dATP*, dADP* 
and dAMP* in the dATP* solution by thin layer chromatography (TLC). The TLC was made with 
a standard mixture of the three deoxynucleotides dATP, dADP and dAMP which were spotted 
on a sheet. The sheet was fluorescent in ultraviolet light and the samples were visible as black 
areas were the florescent was quenched. In the standard mixture we added the dATP* sample 
and single samples of the deoxynucleotides for controls. It was not possible to acquire dATP as 
a single marker due to lack of time, but the dATP mark in the mixture was clearly visible and 
separated from the other deoxynucleosides (Figure 3.2-2). 
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Figure 3.2-2 TLC where the deoxynucleotides in the mixture and the single spots are separated and visible 
under an ultra violet lamp. 
 
Figure 3.2-3 Scintillation count of the mixture with the dATP* sample. Levels of dATP, dADP and dAMP are 
shown in relation to their distance from where they were spotted.   
From the scintillation data it is evident that approximately 95 percent of our solutions is in fact 
containing triphosphates and has not been degraded as we proposed earlier (Figure 3.2-3). 
Due to lack of time no further investigation of the problem was possible and thus only the 
results from the dATP measurements are presented in the rest of this chapter. 
dATP dADP dAMP 
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3.3 ATP and dATP pools before and immediately after UV-irradiation 
The dNTP and ATP content where measured in TK+ ρ+, TK- ρ+ and TK- ρ0 cell lines. The 
measurements were performed without UV-irradiation and immediately after UV-irradiation. 
Previous studies have shown that UV-irradiation does not alter the dNTP pools in TK+ ρ+ and TK- 
ρ+ cells but increases dNTP pools in TK- ρ0 cells which is suggested to correlate with the lack of 
mtDNA [Håkansson et al. 2006; Skovgaard 2009, paper V]. Skovgaard [2009, paper V] also 
report a significant increase in ATP levels in all three cell lines when subjected to UV-
irradiation. This study did not measure the cells before UV-irradiation but uses the time 0 after 
UV-irradiation as control. Our measurement of ATP and dNTP before and after UV-irradiation 
will try to establish if the data [Skovgaard 2009, paper V] used as controls are sufficient and if 
we see different levels of dNTPs and ATP. 
 
Figure 3.3-1 The amount of ATP in exponentially growing osteosarcoma cells. ATP levels were measured 
immediately after UV-irradiation and in non-UV-irradiated ostesarcoma cells. Errors bars are ±S.D. of two 
independent measurements for TK- ρ+ and TK- ρ- and of four independent measurements for TK+ ρ+.   
The TK- ρ+, TK- ρ+ and TK- ρ0 cells shows no significant change in the ATP levels when UV-
irradiated (Figure 3.3-1), but there is a distinct difference in ATP levels between the three cell 
lines (t-test, p < 5%). The TK- ρ0 cells have the lowest amount of ATP both before and after UV-
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irradiation, 0.26 and 0.37 nmol/106 cells respectively. The TK- ρ+ cells has the highest amount 
of ATP, 1.5 nmol/106 cells.  
Figure 3.3-2 dATP content of exponentially growing osteosarcoma cells. The cellular dATP pools where 
measured both after UV-irradiation and in non-UV-irradiated cells. Statistically significant differences (t-test, p 
< 5%) are marked with asterisk. Error bars are S.D. of two independent measurements for TK- ρ+ and TK- ρ0 and 
four independent measurements for TK+ ρ+. 
When the dATP levels in the three cell lines with and without UV-irradiation were investigated, 
a 28 % decrease in the dATP levels were observed in the TK- ρ+ cells when irradiated (t-test, p = 
2.1%) (Figure 3.3-2). The dATP pools in TK+ ρ+ and TK- ρ0 cells do not show statistically 
significant changes. When the cell lines are compared, the dATP pools in TK+ ρ+ and TK- ρ+ 
without UV-irradiation differs with approximately a twofold larger dATP pool in the TK- ρ+ cells 
(t-test, p = 0,1%). The TK- ρ+ cells have the highest amount of dATP both without and with UV-
irradiation, 76 and 105 pmol/106 cells respectively, and the TK- ρ0 cells have the lowest amount 
of dATP of about 15 pmol/106 cells with no change in dATP amount after UV-irradiation. This is 
a 5-fold difference between the TK- ρ+ and TK- ρ0 without UV-irradiation and a 7-fold difference 
with UV-irradiation. 
The TK- ρ+ and TK- ρ0 shows significant differences in dATP levels both with and without UV-
irradiation (t-test, p = 2,8% and p = 1,8 % respectively) . 
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Figure 3.3-3 Shows the ATP and dATP levels of TK- ρ+ and TK- ρ0 cells relative to the ATP and dATP levels of TK+ ρ+ cells. This 
shows that the relative increase in dATP of TK- ρ+ cells compared to dATP of TK+ ρ+ cells, is larger than the relative increase 
of ATP between the same cell lines, while the relative decrease in both dATP and ATP between TK+ ρ+ cells and TK- ρ0 cells is 
approximately the same. 
As seen in figure 3.3-3 the TK- ρ+ cells contain approximately 2.25 and 3 times as much ATP and 
dATP as the TK+ ρ+ cells, respectively, and the TK- ρ0 cells contain just below half the amount of 
both ATP and dATP compared to the TK+ ρ+ cells. As the relative amount of dATP is larger than 
the relative amount of ATP in the TK- ρ+ cells compared with the other cell lines, the proportion 
between ATP and dATP pools is different in the TK- ρ+ cells than in the other cell lines, with a 
higher proportion of dATP compared with ATP. 
 
3.4 Cell sizes of TK+ ρ+, TK- ρ+ and TK- ρ0 cells 
Cell diameters of the three cell lines with and without UV-irradiation were measured to 
investigate if UV-irradiation could have an immediate effect on the cell size. A difference in cell 
size could correlate or perhaps indirectly have an influence with the intracellular 
concentrations of enzymes, substrates and product and thus alter the enzyme kinetics. 
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Figure 3.4-1 Average cell diameters of the different osterosarcoma cells. Error bars are S.D. from to 
independent measurements for TK- ρ+ and TK- ρ- and of four independent measurements for TK+ ρ+.   
 
When the measurements of cell diameter from with and without UV-irradiation are compared 
no statistic significant differences are observed and thus the cell size does not change 
immediately after UV-irradiation in either of the cell lines (Figure 3.4-1). Furthermore the cell 
sizes were not different between the three cell lines. 
 
3.5 Changes in ATP and dATP pools over a 30 hour period 
Because TK1 is important in the synthesis of dNTPs, it is possible that the lack of TK1 could be 
part of the explanation for the increase in dNTP pools in TK- ρ0 cells after UV-irradiation 
observed by Skovgaard [2009, paper V]. Skovgaard [2009, paper V] has not been able to show 
if TK1-deficiency is in fact required for the increase in dNTP pools in the ρ0 cells or not and this 
is investigated in the current experiment with the TK+ ρ+, TK- ρ+, TK+ ρ- and TK- ρ0 cells. To 
investigate if TK1-deficiency is a prerequisite for the increase in dNTP pools, TK+ ρ0 cells must 
namely also be investigated. If the TK+ ρ0 cells with a functioning TK1 react as the TK- ρ0 cells, 
TK1 deficiency played no role in the increase in the dNTP pools after DNA damage but most 
likely the increased dNTP pools were due to the lack of a functioning ETC changing the activity 
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of a different enzyme. Oligomycin were added 24 hours prior to the experiment to inhibit the 
ATPase of the ETC in the TK+ ρ+ cells, and thus mimicking TK+ ρ0 cells. These new cells are able 
to synthesize dTTP with TK1 but they do not have a functional ETC and are referred to as TK+ ρ- 
cells. By measuring immediately after (time 0) and 30 hours after UV-irradiation Skovgaard 
[2009, paper V] observed an increase in the dNTP levels of TK- ρ0 cells. This experiment was 
repeated and done with the same time schedule and thus the findings should be comparable.   
 
Figure 3.5-1 The effect of UV-irradiation on ATP levels in oligomycin-treated TK+ ρ+ cells (TK+ ρ-). TK+ ρ+ and TK+ 
ρ- cells were subjected to UV-irradiation and ATP-levels where measured before and every 6. hour over a time 
period of 30 hours. Error bars are S.D. of two independent measurements for TK+ ρ+ and TK+ ρ- and four 
independent measurements for TK+ ρ+. 
 
The measurements of ATP levels over the 30 hour period do not show any general trend when 
TK+ ρ+ cells are not treated with oligomycin (Figure 3.5-1). One reason the lack of observed 
statistically significant effects on the TK+ ρ- cells may however be generally large variability of 
the ATP measurements. The data from the TK+ ρ- cells have the same problem with large 
standard deviations, but there is an overall significant 3.1-fold increase in the ATP levels from 
the samples before UV-irradiation to the 30 hours samples after UV-irradiation (t-test, p = 
4.7%). Between the samples before UV-irradiation and the 12 hour samples there is no 
significant difference, but between the 12 hour and 30 hour samples there is a significant 4.6 
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fold increase (t-test, p = 1.9%). This could indicate that the increase in ATP levels occur 
between 12 and 30 hours after UV-irradiation but it could also be because of coincidental small 
standard deviations for these two measurements. The increase in ATP in TK+ ρ- cells results in a 
significant 3.5 fold difference between TK+ ρ+ and TK+ ρ- cells after UV-irradiation over a period 
of 30 hours (t-test, p = 4.8%). 
 
Figure 3.5-2 The effect of UV-irradiation on dATP pools in oligomycin-treated TK+ ρ+ cells (TK+ ρ-). dATP levels 
where measured before and every 6 hour after UV-irradiation over a 30 hours period. Error bars are S.D. of at 
least two independent measurements (expect sample from 18 hours after UV-irradiation of TK+ ρ- cells, where 
only one measurement where produced).   
 
The TK+ ρ+ cells do not show significant change in the dATP during the 30 hour period but the 
p-value between the dATP levels in the cells without UV-irradiation and the cells measured 30 
hours after UV-irradiation are very close to being statistical significant (t-test, p = 8.6%)(Figure 
3.5-2). Although some of the measurements are significantly different, it does not seem 
possible to conclude anything with certainty since the general standard deviation is very large. 
It is difficult to make solid conclusions from these data but it could appear as if the dATP levels 
of the oligomycin treated TK+ ρ+ cells and the untreated TK+ ρ+ cells show the same pattern.  
The measurements of dATP levels in the TK+ ρ- cells have the same problem as the TK+ ρ+ cells 
with high standard deviations. Though there is a statistical significant 2.3-fold increase in the 
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dATP pools from samples harvested before UV-irradiation to samples harvested after 30 hours 
of UV-irradiation (t-test, p = 3.4%). 
3.6 Cell size 
The cell size were measured for the two cell lines, TK+ ρ+ and TK+ ρ- cells to investigate if UV-
irradiation could have an effect on the cell size over a period of 30 hours and if the TK+ ρ+ cells 
behave differently than the TK+ ρ- cells. 
 
Figure 3.6-1 Average cell diameters of TK+ ρ+ and TK+ ρ- cells measured every 6 hour over a 30 hour period.  
Error bars are S.D. of at least two independent measurements 
  
Cell size for TK+ ρ+ cells compared with the TK+ ρ- cells show no statistic significant differences 
over a 30 hour period (Figure 3.6-1). There is although a significant increase when comparing 
the diameter of the cells without UV-irradiation with the 30 hours samples for both TK+ ρ+ and 
TK+ ρ- cells (t-test, p = 3,8% and p = 3,9% ). This increase is however already obtained within 
the first 18 hours. The increase in diameter over the period is approximately 10-15% for both 
cell types. Between the 18 and 24 hours after UV-irradiation a significant decrease in the 
diameter of the TK+ ρ+ cells are observed (t-test, p = 1,5%). The decrease in cell size during the 
same time interval after UV-irradiation is not observed in TK+ ρ- cells.  
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4 Discussion  
4.1 Discussion of the method 
As presented in the results some difficulties during the experiments were encountered with 
the dNTP-assay in general but also with the accuracy of some of our measurements. The 
inability to make the dNTP-assay function regarding the dTTP, dCTP and dGTP, were proposed 
to be because of degradation of our dATP* stock solution. The amount degraded was 
measured with TLC to be approximately 5% (figure 3.2-3), and therefore we conclude that 
degeneration of the dATP –stock solution is unlikely to have caused the inability to generate 
results with dTTP, dCTP and dGTP. 
Another suggestion to what could have caused our lack of results was degraded or improperly 
annealed oligonucleotides. Several times during the experimental period new oligonucleotides 
were annealed from the universal primer and template, because of missing results. Hence we 
do not expect the annealing to be the problem if indeed it is the oligonucleotides that are not 
functioning correct. The templates and the universal primer were however the same through 
the entire experiment, and although these are unlikely to degrade they would be our next field 
of interest when trying to resolve why the dNTP-assay is only partially functioning.  
Errors in the washing procedure or the klenow fragments functionality could also cause the 
lack of the dTTP, dCTP and dGTP measurements. However, these causes were discarded as the 
reason for the missing data, since the dATP measurement consistently worked properly with 
the same washing procedure and klenow fragments as the dTTP, dCTP and dGTP 
measurements. Additionally, the klenow fragments were changed during the experiment and 
thus further establishing that the klenow fragement were not the error causing factor. 
The statistical test applied to investigate possible differences between measurements were 
Students T-test with unpaired data. The reason for not using a more complex analytical 
method than Students T-test was because of our small number of replicates (n=2-4). 
Furthermore the accuracy of our experiment must be expected to be lessened by only having 
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two or four independent replicates, which is also observed in our relative high standard 
deviations. As opposed to our difficulties with high standard deviations other studies using two 
replicates are generating results with low standard deviations [Håkansson et al. 2006; Desler et 
al. 2007, Skovgaard 2009, paper V] and thus indicating that we might not have obtained an 
even distribution of single cells after resuspending. 
 
4.1.1 Discussion of the cell types and environment  
When using cells in experimental work, where humane intra- and extracellular mechanisms are 
studied, cancer cells are preferred but also yeast cells are used. Cancer cells can grow almost 
infinite when supplied with sufficient nutrients and they do not generate any ethical problems 
when shipped from an authorized firm. The use of cancer cells is, in many cases, to unravel a 
molecular mechanism in connection with a disease, and thereby to determine a relevant site 
for possible drug treatment in the long term. But when studying the mechanisms in cancer it is 
contradictory to use cancer cells and then mimic cancer to see which mechanisms are affected. 
The cancer cells are behaving like cancer cells and therefore they are expected to already have 
mutations that make them evolve to cancer cells. These mutations are unknown and many 
regulation systems could be changed and not function as they would do in normal human 
tissue. This could in some cases interfere with the experimental outcome, i.e. experiments 
with such cancer prone cells may not provide results that are relevant for normal cells. The 
necessity of using cancer cells, although, is evident knowing that growing normal human tissue 
is difficult, and requires approval from the government because of the ethical issues in using 
human components. Furthermore material is limited compared to cell cultures. When using 
cells in experiments it is worth noticing that some assays and experimental procedures, as our 
UV-irradiation is somewhat impossible to perform with human tissue and instead needs to be 
performed with cell cultures. 
The three cell lines used in this experiment originated from the same host many years ago. 
Since the cells have been separated for many years they could have developed differently and 
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thereby altered their geno- and/or phenotype. When we measured the growth rates they were 
indeed different (figure 3.1-1). The TK- ρ0 cells grew at a slow pace while the TK+ ρ+ and TK- ρ+ 
cells grew 1.2 times faster (doubling time were 14, 12 and 12, respectively). This could be 
explained by the fact that the TK- ρ0 cells do not have any ETC and therefore are less able to 
produce ATP. The high growth rate in the TK- ρ+ cells is because we used a different volume 
percentage fetal calf serum in the medium between the cell lines. The TK+ ρ+ cells were 
supplied with 7.5% FCS but both the TK- ρ+ and the TK- ρ0 cells were supplied with 10%. The 
difference in volume of FCS was due to an attempt to synchronize the growth rates to ease the 
procedure when performing the assays, but this variation in the environment could cause the 
cells to deviate. Tine Skovgaard has measured the growth rate for the TK- ρ+ cells and the 
doubling time were 19.5 hours [Tine Skovgaard 2009, personal communication]. Our TK- ρ+ 
cells grow at a faster pace and thus it appears that the cells might have changed since used by 
Skovgaard [2009, paper V], or that the cellular environments were different. During the growth 
curve experiment we did not change the medium within the third day which we normally did. 
This could perhaps have caused the cells to grow differently from the third to the fourth day 
and change the last sample in the curve. This could give a wrong impression of the cells 
condition and growth rate. Indeed the last samples in the growth curves for the TK- ρ+ and TK- 
ρ0 cell lines are lower than if only the three first measurements were plotted (figure 3.1-1), i.e. 
the growth rate of these two cell lines seems to have decreased over time. This could indicate 
that these cells are affected when the medium is not changed after three days. The growth 
rate of the TK- ρ0 cells is affected more than the TK- ρ+ cells growth rates. An explanation for 
this could be the higher acidification of the medium created by the TK- ρ0 cells when they use 
fermentation as a route of degradation for the pyruvate generated in the glycolysis. This 
acidification was also observed as a color change in the mediums pH buffer, were the color 
changed more quickly in the TK- ρ0 cells than for the other cell lines throughout the entire 
experimental period.  
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Uridine was only added to the TK- ρ0 cells. This was done to ensure pyrimidine synthesis when 
the DHODHase is absent, but might also have caused variations in the environment that are 
not accounted for. It is not certain that the cytosolic concentration of uridine in the TK- ρ0 cells 
was the same as in the TK+ ρ+ and TK- ρ+ cells when uridine only was added to the TK- ρ0 cell 
medium. This could have shifted the dNTP pool balance in the TK- ρ0 cells and thereby affect 
the cells compatibility. As described in section 1.2 Experimental cell lines CPSase catalyzes the 
first step in the de novo pathway of pyrimidine synthesis and by this controls the flow through 
the pathway. CPSase is, among other things, regulated by UTP feedback inhibition. When 
uridine is supplied through the media it can be phosphorylated by the uridine kinase and 
thereby enter the de novo pathway. This obviates the regulation by CPSase, as UMP is now 
synthesized through other mechanisms, and might affect the dNTP pools. However, since the 
CPSase and the uridine kinase are both inhibited by UTP, it is possible that addition of uridine 
to the media does not alter the dNTP pools. Futhermore the dNTP pools and growth rates have 
been tested by Tine Skovgaard in TK- ρ+ cells grown with and without uridine. Neither the pools 
nor growth was affected by uridine [Tine Skovgaard 2010, personal communication]. 
The TK- ρ0 cells are both TK1 and mtDNA deficient. They lack the ETC which is of great 
importance for many cell mechanism including ATP production and the de novo pathway 
through DHODHase. When the mtDNA is absent the cell is deficient of multiple protein 
complexes of the ETC, and this changes the cell by altering or inhibiting the mechanisms in 
which the ETC takes part. Thus the TK- ρ0 cells could differ from the TK- ρ+ and TK+ ρ+ cells in 
many different mechanisms.  
Oligomycin was added to the TK+ ρ+ cells to mimic the TK- ρ0 cells by inhibiting the ATPase. This 
does not inhibit the entire ETC but only the complex which produces ATP. Over time the rest of 
the ETC is also inhibited by oligomycin but the presence of all the complexes in the ETC could 
make the TK+ ρ- cells and the TK- ρ0 cells inner environment differ. To establish if the TK- ρ0 and 
the TK+ ρ- cells are comparable it would also have required a growth curve for the TK+ ρ- cells. 
This could have shown if the cells grew at the same rate or if the TK+ ρ- cells exhibit another 
 36 
 
phenotype. Rasmussen [et al. 2003] have shown that the mechanisms, in which mitochondrial 
dysfunction is converted into mutations, in yeast ρ0 and ρ- cells are different. The ρ0 cells are 
compared to ρ+ cells treated with antimycin A which inhibits cytochrome c, complex III, in the 
ETC. The ρ0 cells showed a mutator phenotype created by the conversion of DNA damage to 
mutation by the error-prone TLS, while the ρ- cells mutator phenotype did not show appear to 
be depended on TLS. This could indicate that the ρ0 and ρ- cells in our case also could differ and 
that treatment with oligomycin does not show enough similarities with the mitochondrial 
deficiency in the ρ0 cells. On the contrary we do not use yeast cells but cancer cells and it is not 
possible to say in what way the change in cell type would modify these findings. Also 
Rasmussen [et al. 2003] treated the cells with antimycin A and not oligomycin, oligomycin 
inhibits a different complex in the ETC than antimycin A and could have influenced the cells 
inner environment differently. An agent that inhibits the entire ETC, or complete removal of 
the mtDNA, would be preferred to only inhibiting ATPase. When we use oligomycin we have 
the possibility to observe if the inhibition of ATP production correlates with an increase in the 
dNTP pools or if it is another part of the mtDNA that influences the dNTP pools. In this way 
oligomycin is useful and the possible other changes in the intracellular environment caused by 
oligomycin are secondary to the function we investigate. 
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4.2 Discussion of the results 
The results in this experiment are incomplete regarding the dNTP measurements and with high 
variability as described in 4.1 discussion of the method and thus we are unable to make any 
scientific interpretations. Nevertheless the results will be discussed for educational purposes 
alone. 
 
4.2.1 ATP measurements 
Cells without UV-irradiation and measured immediately after UV-irradiation are compared 
In the ATP results measured without UV-irradiation and immediately after UV-irradiation, the 
ATP levels did not change upon UV-irradiation in any of the tested cell lines, the TK+ ρ+, TK- ρ+ 
and TK- ρ0 cells (figure 3.3-1). It could be expected that the ATP levels were down-regulated in 
the TK+ ρ+ cell lines because of an up-regulation of TK1 as a response to UV-irradiation, but it 
appears that the UV-irradiation did not affect the ATP levels in any of the cell lines. This could 
indicate that the TK1s influence on ATP levels in the cells is inconsequential immediately after 
UV-irradiation. Another reason for the lack of change observed in the TK+ ρ+ cells ATP levels 
measured immediately after UV-irradiation compared to the cells without UV-irradiation, could 
be explained by a down-regulation of the de novo pathway or an up-regulation of the 
glycolysis. If these regulations occurred one would not be able to measure a decrease in the 
ATP levels even if TK1 was up-regulated. This is however unlikely since changes in ATP levels 
probably happens to slow to be measured immediately after UV-irradiation or the ATP amount 
used by the TK1 might be too small a part of the total ATP present in the cells to be measured. 
Also no change is observed in the TK- cells ATP levels measured immediately after UV-
irradiation compared to the cells without UV-irradiation, which could indicate that the de novo 
pathway is not significantly up-regulated upon UV-irradiation.  
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Comparison of TK+ ρ+, TK- ρ+ and TK- ρ0 cells without UV-irradiation with TK+ ρ+, TK- ρ+ and TK- ρ0 cells  immediately 
after UV-irradiation 
In the TK+ ρ+ cells without UV-irradiation, relatively low ATP levels are observed compared to 
the ATP levels found in the TK- ρ+ cells without UV-irradiation (figure 3.3-1). The ATP value 
found in the TK- ρ+ cells without UV-irradiation minus the ATP value found in the TK+ ρ+ cells 
without UV-irradiation is likely to represent the amount of ATP used by TK1 in normal cells. 
This observation contradicts the earlier speculation where the ATP amounts might be too small 
a part of the total ATP present in the cells to be measured. It is possible that the TK1 uses even 
more ATP in normal cells the difference observed between the TK- ρ+ cells without UV-
irradiation and the TK- ρ+ cells without UV-irradiation, that are not measurable. This would be 
the case if the de novo pathway was up regulated or if the glycolysis was down regulation in 
the TK- ρ+ cells (figure 1.4.1-2). As mentioned in the introduction, it is known that the de novo 
pathway is a much larger consumer of ATP then the salvage pathway, which could mean that a 
small upregulation easily could compensate for a lacking TK1.  
Very low ATP levels are observed in the TK- ρ0 cells, which could be explained by the lack of 
mtDNA in the cells (figure 3.3-1). Since these cells are unable to produce ATP through the ETC 
they rely solely on glycolysis for ATP production. This could also explain the lack of variation in 
the ATP levels measured with and without UV-irradiation (figure 3.3-1), since the cells produce 
less ATP, their ATP level without UV-irradiation might already be at a minimum.   
The TK- ρ+ cells have the highest ATP levels of the cell types and this could be explained by the 
lack of TK1 (figure 3.3-1). In these cells the ETC is still producing ATP but there is no TK1 
present in the cells to make use of them. The high ATP levels in the TK- ρ+ cells could also be 
explained by a down regulation of the de novo pathway or an up regulation of the glycolysis 
(figure 1.4.1-2). However it is not known if lack of TK1 can influence these mechanisms. Thus it 
seems more plausible to be caused directly by the lack of TK1.  
The level of ATP in the TK+ ρ+ cells is between the levels of the TK- ρ0 and the TK- ρ+ cell. In the 
TK+ ρ+ cells both the TK1 is present and the ETC is working which means that ATP is produced 
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by the ATPase and continually is being used by the TK1 to phosphorylate dThd and dUrd (figure 
1.4.1-2). 
The ATP levels both with and without UV-irradiation, in the TK- ρ0 cells were between 0.2 and 
0.4 nmol ATP/106 cells and were the lowest ATP levels measured (figure 3.3-1). The ATP levels 
for the TK+ ρ+ cells were approximately between 0.7 and 1.0 nmol ATP/106 cells and the TK- ρ+ 
cells ATP measurements were between 1.4 and 1.6 nmol ATP/106 cells. Compared to the ATP 
levels measured immediately after UV-irradiation in Skovgaard [2009, paper V] our ATP levels 
measured immediately after UV-irradiation are very low. Our ATP levels in TK- ρ0 cells are 
approximately 1.5 fold smaller than the ATP level of the TK- ρ0 cells in Skovgaard [2009, paper 
V], 2.9  times smaller for the TK+ ρ+ cells and 4.4 times smaller for the TK- ρ+ cells. The large 
difference in ATP levels in the same cell types observed in our experiment compared to 
Skovgaard [2009, paper V] could be due to a differentiation between the cells used. The cells 
used in Skovgaard [2009, paper V] are from the same culture as we use in our experiment, but 
the cells could have changed their geno- and/or phenotype after Skovgaard [2009, paper V] 
used them, perhaps due to mutation or incorrect storage. Despite the large ATP level 
differences between our results and Skovgaard [2009, paper V], we see the same ATP level 
distribution among the cell lines. Hence their results support our findings if only relative values 
are considered.  
 
Comparison of TK+ ρ+ and TK- ρ- cells without UV-irradiation and TK+ ρ+ and TK- ρ- cells 0, 6, 12, 18, 24 and 30 hours 
after UV-irradiation 
In the experiment where ATP was measured in TK+ ρ+ and TK+ ρ- cells without and with UV-
irradiation throughout a 30 hour interval, the standard deviations are generally very large 
which makes it difficult to determine any potential changes (Figure 3.5-1). Even so the ATP 
values from the TK+ ρ+ cells seem too drop from 0 hour with UV-irradiation to 30 hours with 
UV-irradiation. In Skovgaard [2009, paper V] they measured the ATP levels in TK+ ρ+ cells 
immediately after UV-irradiation and 30 hours after UV-irradiation. They found that the ATP 
levels increased after the 30 hours in both TK+ ρ+, TK- ρ+ and TK- ρ0 cells [Skovgaard 2009, paper 
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V]. These results seem more reliable than ours because they have much smaller standard 
deviations. Earlier experiments have also shown that UV-irradiation can cause an 18 hours 
delay in the completion of S phase before being released to G2 phase [Orren et al. 1997; 
Skovgaard 2009, paper V]. Therefore a change in phases could be the reason for the change in 
ATP levels observed in Skovgaard [2009, paper V]. Unfortunately we have not measured cell 
cycle distributions for our cells so it is not possible to determine if the number of s-phase cells 
correlate with our decreasing ATP levels. The ATP increase found in Skovgaard [2009, paper V] 
could suggest that the glycolysis might be up-regulated upon DNA damage (figure 1.4.1-2).  
The level of ATP in the TK+ ρ- cells do not seem to change from 0 hour with UV-irradiation to 30 
hours with UV-irradiation but if you compare the ATP levels from the cells without UV-
irradiation with the level at 30 hours we see a significant increase (figure 3.5-1). An increase 
could mean that the cell up regulates glycolysis upon DNA damage when the ETC is unable to 
produce ATP which correlates with the findings in Skovgaard [2009, paper V]. However, it is 
difficult to conclude anything because of the large standard deviations. 
 
4.2.2 dATP measurements 
In this section we initially discuss the dATP levels measured without UV-irradiation and 
immediately after UV-radiation of the TK+ ρ+, TK- ρ+ and TK- ρ0 cell lines. Subsequently we will 
discuss the dATP pools observed before UV-irradiation and up to 30 hours after UV-irradiation 
in TK+ ρ+ and TK+ ρ- cell lines. Though dATP is the main focus of the following discussion some 
ATP measurements will be included as dATP and ATP pools are connected. 
 
The high relative levels of dATP in TK- ρ+ cells before UV-irradiation may be due to high ATP levels and reduced 
dTTP inhibition of RNR 
As seen in figure 3.3-3 the relative levels of ATP and dATP without UV-irradiation follow the 
same pattern comparing the cell lines, thus indicating that the size of dATP pools are directly 
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related to the size of ATP pools. As it is also shown in figure 3.3-3, the proportions between 
dATP and ATP in TK+ ρ+ and TK- ρ0 cells are approximately the same, which is indicated by 
equally high red and blue bars. As ATP and dATP competes for the activity site of RNR, we 
might expect RNR to uphold a constant equilibrium between ATP and dATP pools, which could 
explain how a relative increase in ATP would result in the same relative increase in dATP. 
Skovgaard [2009, paper V] do however not show a difference in dATP pools between TK- ρ+ and 
TK+ ρ+  cells, in spite of larger ATP pools in the TK- ρ+ cells. 
The dATP pool of TK- ρ+ cells is also slightly proportionally larger than the ATP pool, compared 
to the pools TK+ ρ+ and TK- ρ0 cells. Skovgaard [2009, paper V] showed that the dTTP pools 
were smaller in TK- ρ+ cells than in TK+ ρ+ cells immediately after UV-irradiation. If this is the 
case in our TK- ρ+ cells before UV-irradiation, it could explain why the proportional level of 
dATP compared to ATP is higher in the TK- ρ+ cells than in the TK+ ρ+ cells. As described in the 
introduction, dTTP is inhibiting the de novo synthesis of dATP through RNR. The lack of TK1 
would thereby be expected to increase the level of dATP through reduced inhibition of dATP 
synthesis, caused by low levels of dTTP. We might expect to witness the same proportional 
increase of dATP compared with ATP in the TK- ρ0 cells, but the ATP levels in the TK- ρ0 cells 
might be too low to maintain the dNTP levels. This will be further discussed in a following 
subchapter. 
Decrease of dATP in TK- ρ+ cells immediately after UV-irradiation may be due to experimental errors  
The dATP measurements immediately before and after UV-irraditation (figure 3.3-2) show that 
the dATP pools of TK+ ρ+ and TK- ρ0 cells do not change as an immediate response to UV-
irradiation. The TK- ρ+ cells do however show a significant decrease in dATP levels immediately 
after UV-irradiation. The experiment also shows that the dATP pools of TK- ρ+ cells are 
substantially larger than both the TK+ ρ+ and TK- ρ0 cells and that TK+ ρ+ cells have dATP pools 
of approximately twice the size of TK- ρ0 (figure 3.3-2). This difference in dATP pools between 
the TK+ ρ+ and TK- ρ+ cells immediately after UV-irradiation was not observed by Skovgaard 
[2009, paper V], and may indicate that our cells are behaving very differently from when 
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Skovgaard [2009, paper V] worked with the cells. Lower dATP levels in the ρ0 cells compared to 
ρ+ cells have been observed previously in both UV- and non UV-irradiated cells [Skovgaard 
2009, paper V; Desler et al. 2007] 
The decrease in dATP observed in the TK- ρ+ cell line immediately after UV-irradiation might be 
explained through two different cellular mechanisms. One possibility is a down regulation of 
the dATP synthesis after DNA damage, and the other is an immediate increase in the cells 
consumption of dATP. Obviously there is also the possibility of both mechanisms occur at the 
same time. When the cell is exposed to DNA damage the need for dNTPs to repair damaged 
DNA grows. A normal response to DNA damage is therefore an increase in dNTP synthesizing 
elements [Nakano et al. 2000; Blattner et al. 1999], which makes it unlikely that the TK- ρ+ cells 
would decrease dATP synthesis. It is however possible that the lack of TK1 in the TK- ρ+ cells 
somehow causes a decrease in dATP immediately after UV-irradiation, but as we cannot 
explain the observed decrease in the TK- ρ+ cells immediately after UV-irradiation we find it 
more likely that the decrease is an experimental error and we would need more result as 
validation. 
 
Possible difference in TK1 activity after UV-irradiation between ρ+ and ρ0/- cell lines as a result of low ATP levels 
The right ATP concentration in the cell might be important for the function of TK1, as removal 
of ATP causes disruption of the tetramerization of TK1 and thereby lowered activity [Munch-
Petersen 1993]. The tetramerization of TK1 is also highly dependent on the concentration of 
TK1 and it has been suggested that the TK1 enzyme will be in its dimer form in G1 and early S-
phase irrespective of the ATP concentration because of a low enzymatic concentration. During 
S-phase tetramerizations will form as a result of increased TK1 concentration [Munch-Petersen 
2009]. In our study we have found the average cellular concentration of ATP in cells without 
UV-irradiation varies greatly between cell lines (calculations not presented). It is therefore 
possible that the low concentration of ATP in the TK+ ρ- cells compared with the TK+ ρ+ cells 
might affect the TK1 tetramerization during S-phase and thereby shift the dNTP pool balance. 
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However a measurement of the dTTP pools in all three cell lines as well as in the TK+ ρ- cells 
would help to back up or contradict this hypothesis. The low TK1 activity in ρ0 MDAMB435 cells 
observed by Desler [et al. 2007] might also be explained by ATP affecting tetramerization of 
TK1.  The decrease in TK1 activity reported by Desler [et al. 2007] is however not the reason for 
lover dTTP pools observed in the same cells, and no loss of TK1 activity was observed in ρ0 
HeLa cells in spite of lower ATP levels compared to ρ+ HeLa cells [Desler et al. 2007].  
 
Observed increase in dATP pool of TK+ ρ- cells 30 hours after UV-irradiation could indicate an increase in all dNTP 
pools 
In spite of large standard deviations in our dATP measurements, during the 30 hour 
experiment, the TK+ ρ- cells show an overall significant 2.5 fold and 3.1 fold increases in dATP 
pools and ATP pools, respectively. In contrast, the TK+ ρ+ cells neither show a significant 
increase in dATP nor in ATP pools (figures 3.5-1 and 3.5-2). As we show in this project dATP 
levels of TK- ρ0 cells do not change significantly immediately after UV-irradiation (figure 3.3-2). 
With this in mind the 2.5 fold increase in dATP 30 hours after UV-irradiation correlates well 
with an approximate 2.8 fold increase showed by Skovgaard [2009, paper V]. This tells us that 
apart from large standard deviations, the TK+ ρ- cells resembles the TK-  ρ0 cells observed by 
Skovgaard [2009, paper V] regarding dATP pools size and development during the experiment. 
Previous studies show that all four dNTP pools increase in Human cells lacking mtDNA as a 
response to UV-irradiation, but do not change in human cells with intact mtDNA [Skovgaard 
2009, paper V; Håkansson et al. 2006]. As we only measure dATP it is difficult to say if the 
remaining dNTPs increase, decrease or remain unaltered upon UV-irradiation of the TK+ ρ- 
cells, but we suspect that all four dNTP pools are increased. 
In the following subchapters we will discuss several different cellular functions that might have 
caused the observed increase in dATP levels of TK+ ρ- cells from before UV-irradiation to 30 
hours after UV-irradiation. 
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Increase in ATP might result in an increase in dATP in ρ0 cells 30 hours after UV-irradiation through RNR 
We have shown that TK- ρ0 cells have lower ATP pools than TK+ ρ+ cells both without and 
immediately after UV-irradiation, which probably is a result of the lack of mtDNA in the TK- ρ0 
cells (figure 3.3-1). This could be the cause of the lowered dATP pools seen in the TK- ρ0 cells as 
ATP is both a substrate and a positive regulator in the dNTP synthesis [Eriksson et al. 1979; 
Munch-Petersen 1993]. If indeed lower ATP pools cause lower dATP pools, the increase in 
dATP from before UV-irradiation to 30 hours after UV-irradiation in TK+ ρ- cells, could very well 
be a result of the increase in ATP in the same time interval. As shown by Skovgaard [2009, 
paper V] ATP levels increase in both ρ0 and ρ+ cell lines 30 hours after UV-irradiation, but only 
the dNTP pools of the ρ0 cells increase. This could however be explained by higher degree of 
dATP feedback inhibition of the RNR in the ρ+ cells than in the ρ0 cells. 
If lack of ATP for substrate and positive regulation of the RNR is directly responsible for the 
decreased dATP pool observed in the TK- ρ0 cells compared with the TK+ ρ+ cells (figure 3.3-2), 
we would expect to see lower pools of all four dNTPs in the TK- ρ0 cells as well as the TK+ ρ- 
cells compared to the TK+ ρ+ cells. This theory is partly supported by Skovgaard  [2009, paper V] 
who found that all four dNTP pools were drastically decreased in oligomycin treated TK- ρ+ cells 
compared to all the other cell lines, but not in dGTP and dCTP pools of ρ0 cells compared to ρ+ 
cells. The theory is also supported by Desler [et al. 2007], who observe lower pools of all four 
dNTPs in a ρ0 human skin cancer cell line (MDAMB435) compared to the ρ+. Our measurements 
of dATP in TK+ ρ- and TK+ ρ+ cells without UV-irradiation show no difference in pool size (figure 
3.5-2) between the cell lines, which contradicts the idea of ATP not being sufficient for RNR 
activity in ρ0 and ρ- cells. 
 
Increase in dATP 30 hours after UV-irradiation because of reduced dATP inhibition of RNR 
In response to UV-irradiation the mammalian cell up regulates the transcription of p53R2 
Håkansson et al. 2006], which could be thought to increase the dNTP pools. However a 
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substantial increase in dNTP pools was only observed in ρ0 and not in ρ+ cells by Skovgaard 
[2009, paper V]. Håkansson [et al. 2006] suggests that ρ+ mammalian cells do not show a 
substantial increase in dNTP pools because the increase in concentration of p53R2 as a 
response to UV-irradiation is very low compared to the R2 concentration in S-phase. If this is 
the case we would not expect the increase in p53R2 to cause a substantial increase in the dNTP 
pools of ρ0 cells either.   
As described in the introduction dATP competes with ATP for the activity site of RNR, where 
ATP induces activity and dATP inhibits activity. The feedback inhibition by dATP has been 
shown to be far more effective in mammalian cells than in yeast cells, and it has been 
suggested that the strict dATP feedback inhibition in mammalian cells is the reason they do not 
show an increase in dNTPs upon UV-irradiation while yeast do [Eriksson et al. 1979; Domkin et 
al. 2002; Chabes et al. 2003, A; Skovgaard 2009, paper V]. This lead us to the initial hypothesis 
that low initial concentrations of dATP in the TK+ ρ- cells could cause the increase in dATP 
observed 30 hours after UV-irradiation, through reduced feedback inhibition of RNR. This 
hypothesis is however not in agreement with our results as we only see a significant increase in 
the dATP pools of the TK+ ρ- cells, though the initial dATP pool sizes of the TK+ ρ- and the TK+ ρ+ 
cells are approximately the same (figure 3.5-2). To further test the hypothesis we calculated 
the average initial dATP concentrations in the TK+ ρ+ and the TK+ ρ- cells to 16 µM and 15 µM 
respectively. As both dATP concentrations are approximately the same and relatively high 
compared to the 50 % inhibition concentrations of 1-5 µM dATP [Eriksson et al. 1979], we 
would expect that dATP inhibition would be present and equally influential in both cell lines 
and therefore, not contribute to an increase of dATP in the TK+ ρ- cells without having the same 
effect in the TK+ ρ+ cells. On the other hand small changes in the dATP concentrations can be 
accompanied by large regulatory consequences [Reichard et al. 2000] and we therefore find it 
possible, since we have large standard deviations and our results therefore might not be 
entirely trustworthy, that an increase in TK- ρ0 cells 30 hours after UV-irradiation, as observed 
by Skovgaard [2009, paper V], is possible because of reduced dATP feedback inhibition of RNR.  
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4.2.3 Phases and size of the cells 
 
 
Figure 4.2.3-1 The cell diameter and the level of dATP with proposed cell cycle distribution. 
As described in the results the average cell size has increased in both  TK+ ρ+ and the TK+ ρ-  
cells 30 hours after UV-irradiation compared to TK+ ρ+ and the TK+ ρ- cells without UV-
irradiation. The cell size is however already at its maximum at about 18 after UV-irradiation. 
Furthermore a significant drop in the TK+ ρ+ cell diameter is observed between 18 and 24 hours 
after UV-irradiation. The drop in the TK+ ρ+ cells diameter seems to correlate with the drop also 
observed between 18 and 24 hours in the dATP level. As previously described by Skovgaard 
(2009, Paper V) the cells are arrested in S-phase until approximately 18 hours after UV-
irradiation. This could explain the increase in average cell size, which peaks around 24 hours 
(figure 4.2.3-1), as the cells continue to grow without being able to divide. The release of cells 
into G2 phase and subsequently M phase could also explain the following decrease of average 
cell size as well as the drop in dATP levels at 18 hours after UV-irradiation (figure 4.2.3-1), as 
dNTP synthesis is then down regulated and cells are able to divide. The distribution of cells 
Release into 
G2 -phase G1 -phase G1 and S-phase 
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within various cell cycle phases does, however, not explain the increase in dATP levels at 30 
hours after UV-irradiation, as the distribution of cells in different cell cycle phases should be 
back to normal at this point [Skovgaard 2009, Paper V], It is also peculiar that we should see an 
change in dATP pools as a result of cell cycle distribution when it was not observed by 
Skovgaard [2009, Paper V]. 
 
4.3 Recapitulation  
Our experiments did not generate any results for the dTTP, dCTP and dGTP pools, hence the 
results are incomplete. The lack of results and the large standard deviations makes it difficult 
to deduce anything conclusive from the existing results. Also some of the results did not 
consist with the findings of Skovgaard [2009, paper V] when using the same cell lines and 
method, which indicates that the cells might have differentiated. As the results generally have 
large standard deviations some of the interpretations might be overstated. The analysis and 
interpretation of the results in spite of the great variability were mostly done for educational 
purposes and may not account for scientific findings.   
The results indicate that the ATP and dATP pools are closely related and we suggest that this 
might be due to an ATP/dATP equilibrium maintained by the RNR. We also suggest that the 
dTTP produced by TK1 is contributing to maintaining this equilibrium as dTTP is an inhibitor of 
the RNR. This hypothesis is however not supported by previous works with the same cell lines 
[Skovgaard 2009, paper V] and is in need of further validation.  
The change in dATP pools of TK+ ρ- cells over a 30 hour period resemble the observations made 
for TK- ρ0 cells by Skovgaard [2009, paper V], with a 2.5 and 2.8 times increase respectively. 
This leads us to two assumptions. First it leads us to believe that TK1 does not play an 
important role in the increase of dNTP pool sizes after UV-irradiation, as both TK+ and TK- cells 
seem to behave similarly [Skovgaard 2009, paper V]. Second of all it supports the hypothesis 
already stated by Skovgaard [2009, paper V], that found the increase in dNTP pools after UV-
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irradiation in mammalian cells without mtDNA to relate to deficient oxidative phosphorylation, 
as our TK+ ρ- cells show a similar pattern in dATP production as found in the TK+ ρ0 and TK+ ρ- 
cells observed by Skovgaard [2009 paper V]. 
 
4.4 Further studies 
One of the major deficiencies in our study is the lack of results for the measurements of dTTP, 
dCTP and dGTP pools. It was the objective of the study simultaneously to measure all four 
types of dNTP pools and in future studies it would be interesting to compare new findings with 
the already obtained results. To further investigate the cause of the unsuccessful 
measurements our next step would be to acquire new templates and universal primer. By 
reannealing these and applying standard concentrations of the dNTPs we would be able to 
discard or confirm the oligonucleotides as the cause of our inability to generate results.  
Another interesting field of investigation could be to establish whether it is decreased 
inhibition of RNR which causes the ρ0 cells to increase their dNTP pools 30 hours after UV-
irradiation. This could be done by inhibiting RNR with hydroxyurea, a specific RNR inhibitor, 
and measure the dNTP pools and then making a  comparison between the results of 
[Skovgaard 2009, paper V] and our results. 
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